← Leaderboards
David E Smith
Angion Biomedica Corporation
$8,398,075
Attributed
$8,398,075
Total exposure
7
Grants
7
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $3.6M · FY2007–12$5M$3.8M$2.5M$1.3M$0
'07
'08
'09
'10
'11
'12
Funding mix
By agency
NIH$8,398,075 · 7
By mechanism
R44$7,553,016 · 3
R43$845,059 · 4
Top collaborators
No co-investigators on record.
Most similar at Angion Biomedica Corporation
Same institution · by research overlap
- Youzhi Tong$426,946
- Bert J. W. M. Oehlen$7,885,442
Others in their field
Top investigators on “Dose”
- Lawrence Corey · Fred Hutchinson Cancer Center$251,944,397
- Sharon A Nachman · Johns Hopkins University$213,337,729
- David Heimbrook · Leidos Biomedical Research, Inc.$146,807,554
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$134,297,561
- Douglas S. Hawkins · Children'S Hosp Of Philadelphia$124,321,134
- Peter C Adamson · National Childhood Cancer Foundation$122,197,823
Research focus
DoseMortality Vital StatisticsTissuesIschemic StrokeSmall MoleculePharmaceutical PreparationsNeuronsAnimalsBlood - Brain Barrier AnatomyBaseInjuryPublic Health RelevanceMaleMimeticsLaboratoriesRattusCellsLeadHourCerebrumInfarctionInflammatory ResponseMouse ModelMorbidity - Disease Rate
Grant awards (12)
Novel Neuroprotective/Restorative Therapy for Ischemic Stroke$1,194,283
R44 · FY2012 · NS · contact PI
Novel Neuroprotective/Restorative Therapy for Ischemic Stroke$1,173,372
R44 · FY2010 · NS · contact PI
Novel Neuroprotective/Anti-inflammatory Therapy for Ischemic Stroke$1,071,937
R44 · FY2010 · NS · contact PI
Novel Therapy for Amyotrophic Lateral Sclerosis$926,669
R44 · FY2010 · NS · contact PI
Novel Therapy for Amyotrophic Lateral Sclerosis$432,496
R44 · FY2010 · NS · contact PI
Novel Neuroprotective/Restorative Therapy for Ischemic Stroke$1,123,879
R44 · FY2009 · NS · contact PI
Novel Neuroprotective/Anti-inflammatory Therapy for Ischemic Stroke$1,104,634
R44 · FY2009 · NS · contact PI
Novel Therapy for Amyotrophic Lateral Sclerosis$525,746
R44 · FY2009 · NS · contact PI
Novel Therapeutic for Duchenne Muscular Dystrophy (DMD)$200,506
R43 · FY2009 · AR · contact PI
PARP-1 Inhibitors as Therapy for the Treatment of Stroke$229,277
R43 · FY2008 · NS · contact PI
Novel Therapeutic for Amyotrophic Lateral Sclerosis (ALS)$184,012
R43 · FY2008 · NS · contact PI
Small Molecule Therapeutic for Rheumatoid Arthritis$231,264
R43 · FY2007 · AR · contact PI